Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Cerenome operating margin
Operating margin is operating income as a percentage of revenue.
Cerenome's operating margin for the twelve months ending Jun 30, 2026 was -628.1%. For fiscal 2025 it was -293.5%, against -252.3% the year before. The highest annual figure on record is -238.7% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -293.5% | −41.1 |
| FY2024 | Dec 31, 2024 | -252.3% | +18.8 |
| FY2023 | Dec 31, 2023 | -271.1% | −32.5 |
| FY2018 | Dec 31, 2018 | -238.7% | +530.5 |
| FY2017 | Dec 31, 2017 | -769.2% | −345.9 |
| FY2016 | Dec 31, 2016 | -423.2% | −107.3 |
| FY2015 | Dec 31, 2015 | -316.0% | +338.9 |
| FY2014 | Dec 31, 2014 | -654.9% | −224.1 |
| FY2013 | Dec 31, 2013 | -430.8% | −104.5 |
| FY2012 | Dec 31, 2012 | -326.3% | +42.1 |
| FY2011 | Dec 31, 2011 | -368.4% | −61.6 |
| FY2010 | Dec 31, 2010 | -306.8% | +62.3 |
| FY2009 | Dec 31, 2009 | -369.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2203.6% | −2093.0 |
| Q1 FY2026 | Mar 31, 2026 | -692.5% | −358.6 |
| Q4 FY2025 | Dec 31, 2025 | -420.0% | −143.8 |
| Q3 FY2025 | Sep 30, 2025 | -320.8% | −59.9 |
| Q2 FY2025 | Jun 30, 2025 | -110.6% | +178.4 |
| Q1 FY2025 | Mar 31, 2025 | -333.9% | −137.2 |
| Q4 FY2024 | Dec 31, 2024 | -276.2% | +31.9 |
| Q3 FY2024 | Sep 30, 2024 | -260.9% | −126.6 |
| Q2 FY2024 | Jun 30, 2024 | -289.1% | +306.3 |
| Q1 FY2024 | Mar 31, 2024 | -196.7% | +351.6 |
| Q1 FY2019 | Mar 31, 2019 | -308.1% | +621.9 |
| Q4 FY2018 | Dec 31, 2018 | -134.3% | +441.6 |
| Q1 FY2018 | Mar 31, 2018 | -595.3% | +610.9 |
| Q4 FY2017 | Dec 31, 2017 | -548.3% | −303.5 |
| Q3 FY2017 | Sep 30, 2017 | -930.0% | −273.8 |
| Q2 FY2017 | Jun 30, 2017 | -576.0% | −23.2 |
| Q1 FY2017 | Mar 31, 2017 | -1206.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -244.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -656.2% | – |
| Q2 FY2016 | Jun 30, 2016 | -552.8% | – |
See a number that looks wrong?